跳至主要内容
临床试验/ISRCTN12184897
ISRCTN12184897终止未知

A multi-centre, randomised controlled, non-inferiority and cost-effectiveness trial comparing polyhexanide and chlorhexidine with neomycin to mupirocin for nasal methicillin-resistant Staphylococcus aureus (MRSA) decolonisation amongst adult hospital in-patients

South Tees Hospitals NHS Foundation Trust0 个研究点目标入组 32 人开始时间: 2022年6月6日最近更新:
适应症

试验速览

阶段
未知
状态
终止
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adult in-patient (aged 16 years old or over)
  • 2. Eligible for MRSA screening on admission, based on the local hospital infection control policy, who are found to be colonised with MRSA

排除标准

  • 1. Known hypersensitivity to study treatment(s) or excipients
  • 2. Allergy to peanut and/or soya
  • 3. Day-case admissions
  • 4. Patients identified to be colonised with MRSA in the outpatient setting
  • 5. Previous participation in the TIDE trial or current participation in another trial of a medicinal product that does not allow co-enrolment
  • 6. Patients actively undergoing another decolonisation treatment at the time of recruitment
  • 7. Medical history that might, in the opinion of the attending clinician, put the patient at significant risk if they were to participate in the trial

研究者

相似试验